Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Hutchmed (China)
HCM
5
Lantheus
LNTH
US Stock MarketDetailed Quotes
TENX Tenax Therapeutics
- 5.871
- +0.071+1.23%
Close Apr 28 16:00 ET
24.36MMarket Cap-5.11P/E (TTM)
5.998High5.640Low5.75KVolume5.850Open5.800Pre Close33.51KTurnover0.14%Turnover RatioLossP/E (Static)4.15MShares7.89052wk High0.26P/B24.03MFloat Cap2.77052wk Low--Dividend TTM4.09MShs Float21599978.400Historical High--Div YieldTTM6.17%Amplitude2.770Historical Low5.827Avg Price1Lot Size
Tenax Therapeutics Stock Forum
Sign in to post a comment
$Zoomcar Holdings (ZCAR.US)$ $BioCardia (BCDA.US)$ $Golden Heaven (GDHG.US)$ $Forward Industries (FORD.US)$ $Tenax Therapeutics (TENX.US)$ $CERo Therapeutics (CERO.US)$ $Hong Kong Pharma Digital Technology (HKPD.US)$ $Shuttle Pharmaceuticals (SHPH.US)$ $Brera Holdings (BREA.US)$ $Newton Golf (NWTG.US)$ $Universe Pharmaceuticals (UPC.US)$ $iCoreConnect (ICCT.US)$ $Wellchange (WCT.US)$ $Antelope Enterprise (AEHL.US)$ $American Rebel (AREB.US)$
13
8
$Tenax Therapeutics (TENX.US)$
Tenax Raises Massive $125M War Chest: Phase 3 Heart Failure Drug Trial Gets Major Boost
Tenax Raises Massive $125M War Chest: Phase 3 Heart Failure Drug Trial Gets Major Boost
$Tenax Therapeutics (TENX.US)$ Reuters· just
Tenax Therapeutics Announces $25 Million Private Placement
Tenax Therapeutics Announces $25 Million Private Placement
1
$Tenax Therapeutics (TENX.US)$
Tenax Secures FDA Green Light for Dual Phase 3 Trials in Untreated Heart Condition
Tenax Secures FDA Green Light for Dual Phase 3 Trials in Untreated Heart Condition
$Tenax Therapeutics (TENX.US)$
Tenax Therapeutics Announces $25 Million Private Placement
Wednesday, 5th March at 8:47 am
CHAPEL HILL, N.C., March 05, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (NASDAQ: TENX) (the "Company" or "Tenax Therapeutics"), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, today announced that it has entered into a securities purchase agreement for a private placement financing with RTW Inve...
Tenax Therapeutics Announces $25 Million Private Placement
Wednesday, 5th March at 8:47 am
CHAPEL HILL, N.C., March 05, 2025 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (NASDAQ: TENX) (the "Company" or "Tenax Therapeutics"), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, today announced that it has entered into a securities purchase agreement for a private placement financing with RTW Inve...
2
$Tenax Therapeutics (TENX.US)$ Reuters· 2 mins ago
Tenax Therapeutics : Agreement by FDA to Initiate Second Global Phase 3 Study, Level-2, With First Patient Expected to Be Enrolled This Year
Tenax Therapeutics : Agreement by FDA to Initiate Second Global Phase 3 Study, Level-2, With First Patient Expected to Be Enrolled This Year
$Tenax Therapeutics (TENX.US)$
Tenax Secures FDA Green Light for Dual Phase 3 Trials in Untreated Heart Condition
Tenax Secures FDA Green Light for Dual Phase 3 Trials in Untreated Heart Condition
$Tenax Therapeutics (TENX.US)$
Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF
Wednesday, 5th March at 8:42 am
Amendment to Enlarge Phase 3 LEVEL Study, Increasing Statistical Powering, Accepted by FDA, Expected to be Fully Enrolled Around Year End 2025
Agreement by FDA to Initiate Second Global Phase 3 Study, LEVEL-2, with First Patient Expected to be Enrolled this Year
CHAPEL HILL, N.C., March 0...
Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF
Wednesday, 5th March at 8:42 am
Amendment to Enlarge Phase 3 LEVEL Study, Increasing Statistical Powering, Accepted by FDA, Expected to be Fully Enrolled Around Year End 2025
Agreement by FDA to Initiate Second Global Phase 3 Study, LEVEL-2, with First Patient Expected to be Enrolled this Year
CHAPEL HILL, N.C., March 0...
1
$Tenax Therapeutics (TENX.US)$ Stonepine Capital Management LLC Reports 9.99% Passive Stake in Tenax Therapeutics as of Aug 6, - SEC Filing
$Tenax Therapeutics (TENX.US)$ Reuters· just
Tenax Therapeutics Announces Closing of $100 Million Private Placement and Plans to Accelerate the Oral Levosimendan Phase 3 Program
Tenax Therapeutics Announces Closing of $100 Million Private Placement and Plans to Accelerate the Oral Levosimendan Phase 3 Program
No comment yet
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call
Crypto Angel : Pardon my ignorance but what does "low float" mean?
Stock_Drift OP Crypto Angel : no worries, you’re definitely not ignorant. i hope this helps?
Crypto Angel : Thank you
Stock_Drift OP Crypto Angel : Anytime & you’re welcome.
Graytti : Is this good for those holding?
View more comments...